Stocks and Investing Stocks and Investing
Tue, December 21, 2021
[ 12:00 AM ] - WOPRAI
Jason Mollin Downgraded (AVAL) to Hold and Held Target at $6.2 on, Dec 21st, 2021
[ 12:00 AM ] - WOPRAI
Philip Gibbs Maintained (ATI) at Buy with Decreased Target to $21 on, Dec 21st, 2021
[ 12:00 AM ] - WOPRAI
Stephen Byrd Maintained (ATO) at Buy with Increased Target to $126 on, Dec 21st, 2021
[ 12:00 AM ] - WOPRAI
James Cordwell Downgraded (BABA) to Hold and Decreased Target to $140 on, Dec 21st, 2021
[ 12:00 AM ] - WOPRAI
John Lawrence Initiated (BOOT) at Strong Buy and Held Target at $135 on, Dec 21st, 2021
[ 12:00 AM ] - WOPRAI
Robert Burns Maintained (BNTX) at Strong Buy with Increased Target to $366 on, Dec 21st, 2021
[ 12:00 AM ] - WOPRAI
C. Gregory Peters Maintained (BRO) at Buy with Increased Target to $75 on, Dec 21st, 2021
[ 12:00 AM ] - WOPRAI
Richard Newitter Maintained (BSX) at Strong Buy with Increased Target to $53 on, Dec 21st, 2021
[ 12:00 AM ] - WOPRAI
Patrick Walravens Maintained (BRZE) at Buy with Increased Target to $90 on, Dec 21st, 2021
[ 12:00 AM ] - WOPRAI
George Tong Maintained (BV) at Hold with Decreased Target to $15 on, Dec 21st, 2021
[ 12:00 AM ] - WOPRAI
Richard Newitter Maintained (ZBH) at Strong Buy with Decreased Target to $145 on, Dec 21st, 2021
[ 12:00 AM ] - WOPRAI
Sean Eastman Maintained (ABM) at Buy with Decreased Target to $55 on, Dec 21st, 2021
[ 12:00 AM ] - WOPRAI
Robert Wasserman Initiated (ABCL) at Strong Buy and Held Target at $27 on, Dec 21st, 2021
[ 12:00 AM ] - WOPRAI
Yatin Suneja Downgraded (ACAD) to Hold and Held Target at $28 on, Dec 21st, 2021
[ 12:00 AM ] - WOPRAI
Gregory Renza Maintained (ACAD) at Buy with Increased Target to $34 on, Dec 21st, 2021
[ 12:00 AM ] - WOPRAI
Jason Butler Maintained (ACAD) at Buy with Increased Target to $42 on, Dec 21st, 2021
[ 12:00 AM ] - WOPRAI
Neena Bitritto-Garg Maintained (ACAD) at Hold with Increased Target to $30 on, Dec 21st, 2021
[ 12:00 AM ] - WOPRAI
Tazeen Ahmad Maintained (ACAD) at Hold with Increased Target to $32 on, Dec 21st, 2021
[ 12:00 AM ] - WOPRAI
Marc Goodman Maintained (ALDX) at Buy with Decreased Target to $15 on, Dec 21st, 2021
[ 12:00 AM ] - WOPRAI
Yigal Nochomovitz Maintained (ALDX) at Strong Buy with Decreased Target to $21 on, Dec 21st, 2021
[ 12:00 AM ] - WOPRAI
C. Gregory Peters Maintained (AJG) at Buy with Increased Target to $185 on, Dec 21st, 2021
[ 12:00 AM ] - WOPRAI
Brian Skorney Maintained (BIIB) at Hold with Decreased Target to $258 on, Dec 21st, 2021
[ 12:00 AM ] - WOPRAI
Cory Kasimov Maintained (BIIB) at Hold with Decreased Target to $276 on, Dec 21st, 2021
[ 12:00 AM ] - WOPRAI
Joseph Pantginis Maintained (APTO) at Strong Buy with Decreased Target to $180 on, Dec 21st, 2021
[ 12:00 AM ] - WOPRAI
Roy Buchanan Maintained (ARGX) at Buy with Increased Target to $418 on, Dec 21st, 2021
[ 12:00 AM ] - WOPRAI
Stephen Byrd Maintained (AEP) at Buy with Increased Target to $111 on, Dec 21st, 2021
[ 12:00 AM ] - WOPRAI
Stephen Byrd Maintained (AEE) at Hold with Increased Target to $91 on, Dec 21st, 2021
[ 12:00 AM ] - WOPRAI
Leland Gershell Initiated (ACST) at Buy and Held Target at $36 on, Dec 21st, 2021
[ 12:00 AM ] - WOPRAI
Patrick Trucchio Maintained (VIR) at Strong Buy with Increased Target to $300 on, Dec 21st, 2021
[ 12:00 AM ] - WOPRAI
Joel Beatty Downgraded (VIR) to Sell and Held Target at $36 on, Dec 21st, 2021

Joel Beatty Downgraded (VIR) to Sell and Held Target at $36 on, Dec 21st, 2021


Published on 2024-10-27 19:04:00 - WOPRAI, Joel Beatty
  Print publication without navigation


Joel Beatty of Baird, Downgraded "Vir Biotechnology, Inc." (VIR) to Sell and Held Target at $36 on, Dec 21st, 2021.

Joel has made no other calls on VIR in the last 4 months.



There are 2 other peers that have a rating on VIR. Out of the 2 peers that are also analyzing VIR, all agree with Joel's Rating of Hold. Following are those relevant analyst calls for the last 4 months

  • Anupam Rama of "JP Morgan" Upgraded from Sell to Hold and Increased Target to $37 on, Monday, October 25th, 2021
  • Paul Choi of "Goldman Sachs" Downgraded from Strong Buy to Hold and Decreased Target to $62 on, Wednesday, September 22nd, 2021
Contributing Sources